Salazar-González Jorge A, Angulo Carlos, Rosales-Mendoza Sergio
Laboratorio de Biofarmacéuticos Recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, SLP, Mexico.
Grupo de Inmunología y Vacunología, Centro de Investigaciones Biológicas del Noroeste, SC., Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S., C.P. 23096 Mexico City, Mexico.
Vaccine. 2015 Jul 17;33(31):3650-8. doi: 10.1016/j.vaccine.2015.05.104. Epub 2015 Jun 12.
Chikungunya virus is an emerging pathogen initially found in East Africa and currently spread into the Indian Ocean Islands, many regions of South East Asia, and in the Americas. No licensed vaccines against this eminent pathogen are available and thus intensive research in this field is a priority. This review presents the current scenario on the developments of Chikungunya virus vaccines and identifies the use of genetic engineered plants to develop attractive vaccines. The possible avenues to develop plant-made vaccines with distinct antigenic designs and expression modalities are identified and discussed considering current trends in the field.
基孔肯雅病毒是一种新出现的病原体,最初在东非被发现,目前已传播到印度洋诸岛、东南亚许多地区以及美洲。目前尚无针对这种重要病原体的许可疫苗,因此该领域的深入研究是当务之急。本综述介绍了基孔肯雅病毒疫苗的当前研发情况,并确定了利用基因工程植物开发有吸引力的疫苗的方法。结合该领域的当前趋势,确定并讨论了开发具有独特抗原设计和表达模式的植物源疫苗的可能途径。